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Abstract During the last 10 years, a series of exciting obser-
vations has led to a new theory of pathophysiology using
insights from evolutionary biology and neuroendocrine immu-
nology to understand the sequelae of chronic inflammatory
disease. According to this theory, disease sequelae can be
explained based on redirection of energy-rich fuels from stor-
age organs to the activated immune system. These disease
sequelae are highly diverse and include the following: sickness
behavior, anorexia, malnutrition, muscle wasting–cachexia, ca-
chectic obesity, insulin resistance with hyperinsulinemia, dysli-
pidemia, increase of adipose tissue near inflamed tissue,
alterations of steroid hormone axes, elevated sympathetic tone
and local sympathetic nerve fiber loss, decreased parasympa-
thetic tone, hypertension, inflammation-related anemia, and
osteopenia. Since these disease sequelae can be found in many
animal models of chronic inflammatory diseases with mam-
mals(e.g., monkeys, mice, rats, rabbits,etc.),the evolutionary
time line goes back at least 70 million years. While the initial
version of this theory could explain prominent sequelae of
chronic inflammatory disease, it did not however address two
features important in the pathogenesis of immune-mediated
diseases: the time point when an acute inflammatory disease
becomes chronic, and the appearance of hypertension in
chronic inflammation. To address these aspects more specifi-
cally, a new version of the theory has been developed. This
version defines more precisely the moment of transition from
acute inflammatory disease to chronic inflammatory disease
as a time in which energy stores become empty (complete
energy consumption). Depending on the amount of stored
energy, this time point can be calculated to be 19–43 days.
Second, the revised theory addresses the mechanisms of es-
sential hypertension since, on the basis of water loss, acute
inflammatory diseases can stimulate water retention using a
positively selected water retention system (identical to the
energy provision system). In chronic smoldering inflamma-
tion, however, there is no increased water loss. In contrast,
there is increased water generation in inflamed tissue and
inflammatory cells, and the activation of the water retention
systempersists.Thiscombinationleadstoanetincreaseofthe
systemic fluid volume, which is hypothesized to be the basis
of essential hypertension (prevalence in adults 22–32%).
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Introduction
Despite the enormous progress in genetic and genomic
studies, including extensive analysis of the genome of sev-
eral species, as few as 5–10% of discovered gene functions
are known and many more remain to be discovered. To help
unravel this complexity, some investigators have developed
conceptual frameworks to organize the ever increasing mass
of data and to facilitate incorporation of new information.
Most of us accept the idea that insights into networks are
crucial to elucidate the pathogenesis of chronic diseases (e.g.,
ref. [1]). Indeed, the following network approaches have been
successfullyapplied for differentlevelsofbiomedicalscience:
(1) statistical bioinformatics (correlations of gene expression,
metabolite levels, and protein concentrations without any
causal relationships), (2) intracellular molecular networks as
exemplified by the pathways identified in classical biochem-
istry [2], (3) paracrine cytokine and immune cell networks in
immunological systems [3], and (4) psychoneuroendocrine
immune networks that operate at higher integrative physio-
logical levels [4].
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DOI 10.1007/s00109-012-0861-8Although evolutionary biology and medicine have strong
explanatory power to understand disease- and age-related
problems [5–7], until recently, these disciplines have not
been significantly incorporated into the network theories.
The presence of the neuroendocrine and immune systems
that are instrumental in this report is documented in all
mammals but also in more remote vertebrates such as the
fowl, rainbow trout, or shark. Thus, the evolutionary time
line of the neuroendocrine immune network that is basis of
the present theory goes back at least 400 million years
(distance to the suggested common ancestor).
During the last 10 years, the author has developed a
framework to understand important steps in disease patho-
genesis on the basis of insights from the fields of evolution-
ary biology relevant to the role of neuroendocrine immune
energy regulation in homeostasis. The theory explains many
seemingly unrelated disease sequelae in chronic inflamma-
tory diseases [8–10]. The published concept is shortly reca-
pitulated here (in form of a minireview), and two novel
amendments to the theory are presented.
The framework of evolutionary biology
and neuroendocrine immune energy regulation
in pathophysiology of chronic inflammatory diseases
To meet the challenges of infection and other environmental
stress, an activated immune system has an urgent need for
energy-rich substrates that must be allocated from internal
and external energy stores (glycogen, proteins, triglycerides,
or free fatty acids) [9]. While an activated immune system
requires substantial energy in a quiescent state, this require-
ment rises in an active phase of inflammation. Table 1 lists
energy expenditure under various conditions of different
systems and organs.
Since uptake of energy-rich substrates has an upper
threshold of 20,000 kJ per day (the absorptive capacity in
the gut) [11, 12], it is important for the organism to partition
energy-rich substrates according to fine-tuned mechanisms
of energy regulation. Studies in a number of systems have
demonstrated that circadian rhythms of neuronal, endocrine,
and immune systems can regulate energy metabolism and
partition fuels to daytime and nighttime consumers [9,
13–15]. Since most aspects in a living body occur with
constraints on energy availability, regulation of energy stor-
age and provision occupies a very high position in the
hierarchy of homoeostatic neuroendocrine immune control.
Energy regulation operates not only in the cell but also in
coordinating centers of the brain and in endocrine organs
that integrate organismal function. Important questions con-
cern the origin of these regulatory mechanisms and the
extent to which they have been subject to positive selection
in the context of chronic inflammation.
It has been hypothesized that genes responsible for ener-
gy regulation have been positively selected under conditions
without chronic inflammation [8, 10]. Chronic diseases and
Table 1 Energy expenditure
of systems and organs
under various conditions
[9, 11, 12, 32, 53]
10,000 kJ02,388 kcal
MR metabolic rate
aSuch a high energy expenditure
can be maintained only for
a very short period of time
bSee derivation of energy need
in ref. [9]. Leukocytes use
all types of fuels, but the main
source is glucose and glutamine
making roughly 70% of the
fuels needed [54–56]
cEnergy need is difficult to
estimate independent of the
immune system in these organs
System/organ Energy expenditure per day (kJ/day)
Total body basal MR 7,000
Total body MR with usual activity 10,000
Total body MR of a Tour de France bicyclist 30,000
a
Total body MR during minor surgery 11,000
Total body MR with multiple bone fractures up to 13,000
Total body MR with sepsis 15,000
Total body MR with extensive burns 20,000
Total body daily uptake (absorptive capacity in the gut) 20,000
Immune system MR under normal conditions 1,600
b
Immune system MR moderately activated 2,100
b
Central nervous system MR 2,000
Muscle MR at rest 2,500
Muscle MR activated 2,000–10,000 and more
Liver
c MR 1,600
Kidneys MR 600
Gastrointestinal tract
c MR 1,000
Abdominal organs (together)
c MR 3,000–3,700
Lung
c MR 400
Heart MR 1,100 (and more when activated)
Thoracic organs (together)
c MR 1,600–2,400
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negative selection pressure in evolution. Chronic inflamma-
tory diseases can lead to loss of reproduction potential
because affected individuals are at strong disadvantage.
Such individuals can be excluded or impaired in the com-
petition for food; they can also have low social status in the
group and limited choice or availability of sexual partners.
In addition, intense, persistent inflammation can inhibit the
hypothalamic–pituitary–gonadal axis, leading to impairment
of fertility as demonstrated in studies on the effect of chronic
inflammatory diseases on fertility despite good medical
control [16–20].
In some situations, however, the presence of a chronic
inflammatory disease may not exert any selective pressure
despite its potential severity. Many chronic inflammatory
diseases only become manifested in patients at older ages.
Because of the short life expectancy in the past, our ances-
tors have not suffered from the chronic inflammatory dis-
eases that we know today. Their genes have been positively
selected for different aspects such as reproduction, muscular
work, defense against infections, metabolism, and similar
important activities. Furthermore, in the past history, there
may have been no time for natural selection. This situation
would occur if various chronic inflammatory diseases did
not exist until 100 to 200 years ago. Indeed, there is a
suggestion that rheumatoid arthritis and Crohn’s disease,
for example, are relatively new diseases.
It has been hypothesized that the genes relevant to the
etiology of today’s chronic inflammatory diseases have been
positively selected for their effects on normal host defense
as well as the host response to serious, albeit non-life-
threatening, inflammatory episodes in contrast to chronic
inflammatory diseases (Table 2)[ 8]. These issues remain
under investigation. Nevertheless, despite uncertainty about
their origin, many genes have been linked to an increased
risk or more severe forms of chronic inflammatory diseases
including polymorphisms for human leukocyte antigens
(HLA) and polymorphisms for other elements of the im-
mune system detected by genome-wide association studies.
However, these genes were most probably evolutionarily
conserved because they supported positive selection at
younger ages. This concept was developed in the 1950s in
the context of aging research and the theory was called
“antagonistic pleiotropy” [7].
An example of antagonistic pleiotropy illustrates these
ideas. HLA DR4 (DRB1*04) is a well-known risk factor for
rheumatoid arthritis and other chronic autoimmune diseases,
but HLA DR4 (DRB1*04) also has a strong negative asso-
ciation with dengue hemorrhagic fever [21]. HLA DR4
(DRB1*04) homozygous individuals are 12 times less likely
to develop dengue hemorrhagic fever [21]. Thus, it seems
likely that HLA DR4 (DRB1*04) was positively selected to
overcome dengue hemorrhagic fever but not to stimulate
rheumatoid arthritis and other autoimmune diseases in later
life. Further examples of antagonistic pleiotropy are dem-
onstrated in Table 3. Antagonistic pleiotropy can explain
why genes positively selected at younger ages can have
disease-supporting roles in later life independent of the
selection process.
In summary, it seems plausible that specific genes have
not been selected or conserved in evolution because of their
putative role in chronic inflammatory diseases, either posi-
tive or negative. Rather, genes, signaling pathways, and
networks operative in symptomatic chronic inflammatory
diseases were likely adapted from normal physiology or
serious, albeit non-life-threatening, inflammatory episodes;
the outcomes of such transient events, for which recovery is
possible, would not have blocked the gene transmission to
the progeny (Table 2). The same situation is true for neuro-
endocrine immune regulation of energy storage and energy
allocation to consumers.
On the basis of these considerations, typical disease-
related sequelae that are very common in chronic inflam-
matory diseases have been linked to transient inflammatory
episodes [9, 10]. Here, these sequelae have an important
function in supporting the transiently activated immune
system and tissue inflammation (Table 4). The disease se-
quelae noted in Table 4 have usually been considered as
independent phenomena in the absence of a unifying model
to explain both their prominence and their coexistence. As a
common denominator, the redirection of energy-rich fuels
from energy stores to the activated immune system can
explain systemic disease sequelae [9]. This theory can also
explain the observed disturbances of the neuroendocrine
immune regulation in chronic inflammatory diseases [9].
In this conceptualization, the induction of systemic
responses results from an appeal for energy-rich substrates,
called the energy appeal reaction [9]. In this scenario, the
energy appeal reaction has been positively selected for tran-
sient inflammatory episodes. Respective genes and networks
Table 2 Non-life-threatening episodes of inflammation that can occur
normally and form the basis of selection and conservation during
evolution
Immune response due to infection
Control of inner and outer body surfaces
Reactions with foreign bodies
Wound healing
Immunosurveillance in tissue
Implantation of stems cells into injured tissue
Implantation of a blastocyst into the uterine epithelium
Immune phenomena facilitating semiallogenic pregnancy
Replacement of cells and tissue (physiological regeneration and
degeneration)
Apoptosis
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(transient inflammatory process). However, prolonged opera-
tion of these adaptive programs such as in chronic inflamma-
tory diseases of today can in itself become pathogenic. Thus,
one can add the “systemic response” to the list of classical
etiologic factors of chronic inflammatory diseases (Table 5)
[10]. The “systemic response” in itself can be disease
perpetuating.
Refinement of the existing theory
From acute to chronic inflammatory
disease—where is the boundary?
An acute infectious disease can be self-limiting and involve
an innate immune response of 2 to 3 days; the subsequent
phase of the adaptive immune response can last approxi-
mately 3 to 4 weeks. Similarly, many transient inflammatory
episodes include a healing phase that involves adaptive
immune responses (Table 2). The typical germinal center
reaction of affinity maturation of B cells occurs for 3 to
4 weeks from the beginning to end [22, 23]. The accompa-
nying proliferative T cell response undergoes a similar time
course [24]. The response of the adaptive immune system
with a maximum of proliferation until days 12 to 14 and
subsequent contraction until days 21 to 28 is surprisingly
constant in various acute infectious diseases [24]. Upon
generation of immunological memory, the entire process
can be markedly shortened, and this was a selection advan-
tage [24]. An important question concerns the dynamics of
this response: why do the increase and decrease of the
adaptive immune response not last longer?
Acute self-limiting infectious diseases can be very energy
consuming although, in the presence of disease-induced
sickness behavior and related anorexia (Table 4)[ 9, 25],
intake of energy-rich substrates can be significantly
inhibited. To explain these seemingly disparate observa-
tions, it can be proposed that sickness behavior represents
an element of an adaptive program that has been positively
selected for transient immune and inflammatory reactions to
limit energy utilization for such activities as foraging and
courtship behavior [8, 26, 27]. In such a situation, the
immune response can not last forever because energy stores
run empty.
Furthermore, sickness behavior can restrain activity and,
for example, confine the affected individual to a safe place
to keep away predators [8, 26, 27]. In considering energy
stores available during these responses, it is important to
note that storage occurs primarily in fat tissue (12 kg of
triglycerides in the body of a contemporary person,
500,000 kJ), as well as in the liver (150 g glycogen,
2.500 kJ) or muscles (300 g glycogen, 5,000 kJ; 6–7k g
muscle protein, 50,000 kJ) [11, 12].
Under conditions of sickness behavior and anorexia with-
out uptake of energy-rich substrates but an increased
sickness-related metabolic rate (Tables 1 and 6), the total
amount of stored energy would only last for 19 to 43 days in
females and 28 to 41 days in males (Table 6). The number is
relatively similar for domestic fowl which have an evolu-
tionary distance to Homo sapiens of 300 million years
(Table 6). In other words, an acute consuming infectious
disease that uses all energy stores can only last until the
stores are empty, say 19 to 43 days. Thus, the evolutionarily
positively selected increase and decrease of an adaptive
immune response must fit into this prespecified time frame.
Due to the physical restrictions of energy storage under
natural paleolithic conditions, an acute infectious disease
may not last much longer than 3 to 6 weeks. It can be
hypothesized that energy considerations can help explain
the relatively constant time course of an adaptive immune
response in the context of acute infection.
Table 3 Examples of antagonistic pleiotropy for genes that increase risk or severity of chronic inflammatory diseases
Genes Chronic inflammatory disease Pleiotropic meaning outside of chronic
inflammatory diseases (with selection advantage)
Refs.
HLA DR4 (DRB1*04) Rheumatoid arthritis and other
autoimmune diseases
Decrease of risk of dengue hemorrhagic fever
(defense against infectious agents)
[21]
HLA B27 Ankylosing spondylitis and other
axial forms of spondyloarthritis
Decrease of viral infection
(defense against infectious agents)
[57, 58]
PTPN22 1858 C>T* Many autoimmune diseases Higher body mass index, higher waist-to-hip
ratio in women (storage of energy-rich fuels)
[59]
CTLA4 49 A>G Many autoimmune diseases Better defense against hepatitis B virus and
Helicobacter pylori (defense against infectious agents)
[60, 61]
NOD2/CARD15 Crohn’s disease Hypertension (activation of the sympathetic nervous system) [62]
*PTPN22 1858 C>T is associated with many autoimmune diseases but is also linked to a higher risk of infection. This seems to contradict the
theory of antagonistic pleiotropy. Until today, nobody has focused on a possible selection advantage in the context of reproduction. It might well be
that this mutation is related to a decreased T cell - dependent rejection of the semiallogenic fetus. This would support reproduction. The PTPN22
1858 C>T mutation is linked to increased risk of endometriosis which already demonstrates a role in the context of reproduction [63]
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timepoint at which energy stores were exhausted, the affected
person would probably have died due to inanition and starva-
tion, preventing transfer of genes to any offspring. If, howev-
er,animmuneresponselastedforashorterperiod,theaffected
personcould surviveand beabletotransferfavorable genesto
offspring. These considerations thus suggest that the time
point of total energy consumption marks the upper threshold
of an acute disease period for which genes, signaling path-
ways, and networks can be subject to positive selection. But
what happens to the survival of the individual after this
physical threshold of total energy consumption?
It can be hypothesized that networks for more persistent
inflammatory diseases do not exist because they have not
undergone the pressure of positive selection. If a disease is
progressive and longstanding (e.g., autoimmunity) and ther-
apies are available to stop lethal emaciation (i.e., immuno-
suppression), a chronic phase can develop. For the chronic
phase of such immune-mediated diseases, the organism
would lack positively selected genes, signaling pathways,
and networks to be able to stop the chronic disease in a
coordinated fashion. Thus, sickness behavior and energy
disturbance would remain and impair the function of the
individual. It becomes a perpetuating factor (Table 5).
The framework of evolutionary biology and neuroendocrine
immune energy regulation thus defines the point of transition
from acute disease to chronic disease as the time point of
complete energy consumption (19–43 days). In this regard,
thepointcanrepresenta range intime becausetheconsumption
curve depends on stored energy reserves (Table 6).
Table 4 Sequelae of chronic inflammatory diseases in the light of altered energy regulation
Disease sequelae Pathophysiological elements in chronic inflammation leading to energy
allocation to an activated immune system
Depressive symptoms/fatigue Cytokine (e.g., IL-1β)-driven sickness behavior and fatigue which increase time at rest
(muscles and brain in an inactive state)
Anorexia Consequence of sickness–behavior and fatigue
Malnutrition
a Consequence of anorexia and sickness behavior
Muscle wasting–cachexia Protein breakdown in muscles as a consequence of anorexia, sickness behavior and androgen deficit
Cachectic obesity Protein breakdown in muscles as a consequence of anorexia and sickness behavior
(protein breakdown > fat breakdown)
Insulin (IGF-1) resistance
(with hyperinsulinemia)
Cytokine (e.g., TNF)-induced insulin signaling defects in the liver, muscle, and fat tissue but not in
immune cells. Immune cells need insulin so that high insulin levels support the activity of the immune
system (similar for IGF-1)
Dyslipidemia
b Cytokine-driven acute phase reaction of lipid metabolism leading to higher delivery of cholesterol
and other lipids to macrophages
Increase of adipose tissue in the
proximity of inflammatory lesions
Presence of adipose tissue surrounding lymph nodes and in the proximity of inflammatory lesions
reflects a local store of energy-rich fuels (increased local estrogens might be important to drive local
accumulation of adipose tissue). Adipokines play a proinflammatory role
Alterations of steroid hormone axes Cytokine/leptin-driven hypoandrogenemia supports muscle breakdown and protein delivery for
gluconeogenesis and support of an activated immune system (alanine, glutamine).
Cortisol-to-androgen preponderance in chronic inflammation is catabolic
Elevated sympathetic tone and
local sympathetic nerve fiber loss
Cytokine-driven increase of SNS activity increases gluconeogenesis and lipolysis. The parallel loss
of sympathetic nerve fibers in inflamed tissue supports local inflammation [64]. It also stimulates
lipolysis in the surrounding adipose tissue because sympathetic nerve fibers are increased there [65]
Hypertension Cytokine-driven activation of the water retention system due to systemic water loss during inflammation
Decreased parasympathetic tone Cytokine-driven decrease of the PSNS activity supports allocation of energy-rich fuels to an
activated immune system
Inflammation-related anemia Cytokine-driven anemia is linked to reduced energy expenditure for erythropoiesis, increased time at
rest, and insulin resistance (see above), all of which support energy allocation to the immune system
Osteopenia High calcium and phosphorus are mandatory for energy-consuming reactions. Driven by cytokines
and PTH-related peptide during inflammation. In addition, an activated SNS and HPA axis stimulate
bone resorption
References that demonstrate the respective disease sequelae and the pathophysiological explanation can be found in detail in reference [9]
HPA axis hypothalamic–pituitary–adrenal axis, IGF insulin-like growth factor, IL interleukin, PTH parathyroid hormone, SNS sympathetic nervous
system, TNF tumor necrosis factor
aHypovitaminosis D and others, deficiency in zinc, iron, copper, magnesium, and similar
bDyslipidemia in chronic inflammation reflects low levels of HDL cholesterol and/or apolipoprotein A–I and appearance of an “inflammatory HDL
subfraction” with increased serum amyloid A and ceruloplasmin
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an evolutionary link between inflammation and hypertension
Acuteinflammatoryepisodesrequire abundantenergyand are
often accompanied by local and systemic water loss(Table 7).
Local water loss is particularly important when the inflamed
tissue has an exposed surface area such as the skin or to inner
surfaces of the gastrointestinal, respiratory, or urogenital tract.
For example, water loss through skin wounds depends on the
surface area and can amount to 0.35 ml/cm
2/day (area, 30×
30 cm
20315 ml/day) [28]. Another example of water loss
relates to insensible perspiration. Under normal conditions in
Table 5 The etiological factors
in chronic inflammatory
diseases
Genetic susceptibility (gene polymorphisms; polygenic)
Complex environmental priming (microbes, toxins, drugs, injuries, radiation, cultural background,
and geography)
Immune response (exaggerated and continuous immune response against harmless self or foreign antigen)
Tissue destruction (continuous wound response without proper healing but fibrotic scarring)
Systemic response (support of the immune and wound response by redirection of energy-rich fuels leading to
unwanted disease sequelae)
Table 6 Total consumption time in human evolution
Species Date range (Ma, ka) Body mass (kg) Sickness-related
metabolic rate
a
(kJ/day)
Stored energy (kJ) Total consumption
time (day)
Females
A. afarensis 3.9–3.0 Ma 29 7,925 152,448 19.2
A. africanus 3.0–2.4 Ma 30 8,061 163,943 20.3
P. boisei 2.3–1.4 Ma 34 8,581 195,237 22.8
P. robustus 1.9–1.4 Ma 32 8,325 177,921 21.4
H. habilis 1.9–1.6 Ma 32 8,325 177,921 21.4
H. ergaster 1.9–1.7 Ma 52 10,612 404,052 38.1
H. erectus 1.8 Ma–200 ka 52 10,612 404,052 38.1
H. neanderthalensis 250 ka–30 ka 52 10,612 372,884 35.1
H. sapiens 100 ka–1900 50 10,406 294,034 28.3
H. sapiens Today (USA) 74 12,660 545,052 43.1
Males
A. afarensis 3.9–3.0 Ma 45 9,872 275,502 27.9
A. africanus 3.0–2.4 Ma 41 9,423 238,194 25.3
P. boisei 2.3–1.4 Ma 49 10,302 303,277 29.4
P. robustus 1.9–1.4 Ma 40 9,308 214,241 23.0
H. habilis 1.9–1.6 Ma 37 8,952 198,282 22.2
H. ergaster 1.9–1.7 Ma 66 11,956 485,500 40.6
H. erectus 1.8 Ma–200 ka 66 11,956 485,500 40.6
H. neanderthalensis 250 ka–30 ka 70 12,313 509,846 41.4
H. sapiens 100 ka–1900 65 11,865 377,130 31.8
H. sapiens Today (USA) 86 13,648 558,908 41.0
Animals
Domestic pig (adult) 65 Ma distance
b 100 13,009 754,611 58.0
Domestic fowl (adult) 300 Ma distance
b 3.7 1,159 21,177 18.3
Time to total consumption was calculated based on known height and weight of our ancestors [66] using published formula [12, 32]. The last
column gives the total consumption time as the ratio of stored energy divided by the sickness-related metabolic rate. Stored energy is a sum of
stored triglycerides (roughly 54% of total fat) and usable proteins (roughly 38% of total proteins) using the conversion factor 37.6 kJ/g triglycerides
and 16.7 kJ/g protein, respectively [32]. The small amount of glycogen was not entered into the calculation
aThe sickness-related metabolic rate is given as the basal metabolic rate multiplied by a factor of 1.5 (an 150% increase), which was demonstrated
to be a good energy expenditure measure for moderate activation of the immune system [9, 67]
bDistance means time in evolution to most recent common ancestor
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can reach 0.5 ml/kg/h (example, 80 kg and 24 h0960 ml/day)
[29]. During surgical intervention, which is a model of mild
acute inflammatory activation, water loss by insensible perspi-
r a t i o nc a na m o u n tt o1m l / k g / h( e x a m p l e ,8 0k ga n d2 4h 0
1,820 ml/day) [29]. These numbers show that loss of water can
be quite high during acute inflammatory episodes.
In addition to physical loss of water via outer and inner
surfaces, many metabolic reactions that degrade storage
forms of energy-rich substrates need water for hydrolysis
(Fig. 1)[ 30–32]. For example, the breakdown of one mol-
ecule of glucose from glycogen needs two molecules of
water (Fig. 1, pink area in left upper corner); triglyceride
breakdown needs three molecules of water for three mole-
cules of free fatty acids (Fig. 1, pink and yellow area on the
left side); and degradation of muscle protein needs particu-
larly many molecules of water (Fig. 1, brown area in right
upper corner) [31]. If amino acids are completely degraded
within the urea cycle in the liver, one molecule of water is
needed for one molecule of amino acid (Fig. 1, pink area in
the left upper corner).
Furthermore, the generation of the Cori cycle between the
lactate-producing inflamed tissue and the glucose-producing
liver [33], involving gluconeogenesis, needs five molecules
of water to reactivate one molecule of lactate (Fig. 1, red
lines with arrows) [31]. Finally, the operation of a proper
adaptive immune response with proliferation of B cells and
Tcells and proliferation of innate immune cells (neutrophils,
monocytes) in primary and secondary lymphoid organs
needs enormous amounts of water (Fig. 1, green area in left
lower corner) [31]. The water loss described above is water
loss in the system (liver, muscle, fat tissue, lymphoid
organs, and others). It is not local water loss in inflamed
tissue because here, in contrast, water is produced.
Water is formed when glucose, amino acids, and free
fatty acids undergo degradation in the Krebs cycle and
during oxidative phosphorylation; these processes occur in
the mitochondria of activated cells in inflamed tissue (Fig. 1,
orange area). Thus, important differences exist for water loss
from the system and the generation of water from locally
inflamed tissue. The amount of locally formed water can be
large (Fig. 1, orange area), but usually water is lost rapidly
in the environment of inflamed tissue via outer and inner
surfaces (Table 7).
To overcome systemic water loss during acute inflamma-
tory episodes and events such as trauma, hemorrhage, and
burns, a water retention system is activated. The key ele-
ments of this system are the sympathetic nervous system
(SNS) that activates the renin–angiotensin–aldosterone
pathway [34], and the hypothalamic–pituitary–adrenal
(HPA) axis with ACTH, aldosterone, and cortisol. ACTH
can stimulate aldosterone as well as cortisol, which also has
mineralocorticoid activity [35]. It may not be a simple
coincidence that the SNS and the HPA axis can redirect
energy-rich substrates from energy stores to the activated
immune system as well as serve as major water retention
systems. In this context, it is important to recall that the
acute adaptive response described by Selye in the 1940s was
considered a “nonspecific” alarm reaction [36]. Today we
can say that Selye’s alarm reaction was not “nonspecific”
but rather had important physiologic functions as both, a
highly specific energy appeal reaction (as described earlier
[9, 10]) as well as a specific water retention reaction.
The SNS and the HPA axis are supported by other alarm
hormones such as vasopressin (which is lipolytic and water
retentive), growth hormone (glucogenic, lipolytic, and water
retentive), and insulin (lipogenic and water retentive). Dur-
ing transient inflammatory episodes, due to sickness behav-
ior and anorexia, lipogenic insulin most probably plays a
minor role because insulin secretion activated by the pres-
ence of carbohydrates would be downregulated. Thus, while
sickness behavior may have antilipogenic consequences by
suppressing insulin secretion, it can also be prolipolytic
through activation of the SNS and the HPA axis. It leads
to redirection of stored energy to the activated immune
system.
These ideas can explain other activities of physiological
mediators and provide insights in findings that, for example,
water retention hormones such as angiotensin II have proin-
flammatory activities [37]. Angiotensin II uses the important
proinflammatory signaling cascade of NF-κB activation
similar as TNF [38]. Inhibition of the renin–angiotensin–
aldosterone system by angiotensin-converting enzyme
inhibitors or angiotensin II receptor antagonists exert anti-
inflammatory effects as summarized elsewhere [39]. In the
setting of acute inflammatory episodes such as infectious
disease, it is important that the energy appeal reaction and
Table 7 Water loss during transient inflammatory episodes
Local loss of water from inflamed tissue
Loss from wounds by evaporation
Loss from inflamed tissue into the gastrointestinal tract
(diarrhea, vomiting)
Loss into inflamed upper and lower airways
(rhinitis, perspiration, expectoration)
Third-space fluid shifts into pleural cavity, peritoneal cavity, and similar
Systemic loss of water
By perspiration during fever
By sweating during fever
By triglyceride and glycogen breakdown from fat tissue and liver
By gluconeogenesis from lactate
(Cori cycle between liver and inflamed tissue)
By muscle breakdown in the context of cachexia
By complete amino acid breakdown in the urea cycle in the liver
By cell proliferation (leukocyte proliferation in lymphoid tissue)
J Mol Med (2012) 90:523–534 529530 J Mol Med (2012) 90:523–534the water retention reaction support the proinflammatory
process to eliminate the infectious agent. It can be hypoth-
esized that the water retention hormone angiotensin II is
immunomodulatory in this respect.
In conclusion, the water retention system shows impor-
tant similarities to the energy provision system, with opera-
tion of the two interacting systems subject to positive
selection in evolution to overcome serious, albeit non-life-
threatening, transient inflammatory episodes (Table 2). This
possibility is supported by the proinflammatory activity of
water retention hormones. It is therefore important to con-
sider the role of the water retention system in settings of
chronic inflammation such as may occur in aging as well as
rheumatic and autoimmune diseases undergoing medical
treatment (after entering the chronic phase).
Both the aging process and medically treated chronic in-
flammatory diseases are accompanied by mild inflammation,
a state that one might call low-grade smoldering chronic
inflammation [40, 41]. In these settings, circulating cytokine
levelscan be 5 to10 times higherthannormal (e.g., IL-6 from
2 pg/ml to 10–20 pg/ml), and the overall stimulus might be
strong enough to induce a mild systemic water retention and
energy appeal reaction (responses shown for low IL-6 serum
concentrations in ref. [42, 43]). Since no positively selected
programs exist for aging [44] and chronic inflammatory dis-
eases[8,45],genes,signalingpathways,andnetworksthatare
operative in this setting are similar to those that determine
acute episodes of inflammation (Table 2).
Under conditions of local inflammation with exposed
outer and inner surfaces, circulating cytokines from in-
flamed tissue activate the energy appeal and water retention
reaction. Since the local inflammatory process leads to water
loss over local surfaces, locally formed water—by degrada-
tion of energy-rich fuels in activated inflammatory cells
(Fig. 1, orange area)—can be rapidly lost via the exposed
surface (Fig. 2a). It can be hypothesized that, in the presence
of local and systemic water loss, the water retention system
will not induce hypertension under these acute inflammato-
ry conditions.
The situation of water retention might be very different
depending on the setting and operation of different mecha-
nisms of water loss. These mechanisms would include the
following events which may be present during disease: local
water loss through outer/inner surfaces (Table 7), water loss
due to systemic effects such as fever (Table 7), recirculation
of formed water from activated inflammatory cells; and
cytokine-activated water retention and energy appeal reac-
tion. Depending on the operation and extent of these mech-
anisms, systemic hypertension could result from the
continuous activation of a water retention and energy appeal
reaction but without the usual water loss (Fig. 2b).
Indeed, in aging and in chronic inflammatory diseases,
both the SNS and the HPA axis are chronically activated
[41, 46–48]. In addition, there are obvious signs of volume
overload in chronic inflammatory diseases because serum
levels of atrial natriuretic factor and NT-brain natriuretic
factor are markedly increased in different diseases [49–52].
NT-brain natriuretic factor decreased with TNF neutraliza-
tion therapy but increased under therapy with volume reten-
tion—inducing glucocorticoids [49, 51].
The revised version of the theory predicts that the operation
of these mechanisms will not depend on the site of inflamma-
tion and whether it occurs in arteries, kidneys, gastrointestinal
tract, joints, or at various tissues with inflammatory cells. The
key feature relates to the production of cytokines of inflamma-
tory cells, their activation of the energy appeal and water
retention reaction, and the extent of water loss via inner and
outer surfaces. The magnitude of these changes would deter-
mine any detrimental effect on the induction of hypertension.
Since prevalence of essential hypertension in adults is 22–32%,
these theoretical considerations are highly clinically relevant.
As noted above, the energy appeal reaction and water reten-
tion reaction appear to be the result of selection in evolution for
their role in transient inflammatory episodes. Induction of en-
ergy appeal reaction and water retention reaction provide a
survival value if used for a short period of time. However,
prolonged operation of these adaptive programs such as in
chronic inflammatory diseases of today can in itself become
pathogenic because there is no program to counteract continu-
ouswaterretentionandenergyappealreactionduringlong-term
age-related inflammation and in chronic inflammatory diseases.
Conclusions
The study of evolutionary medicine combined with new
insights into energy regulation (including the role of
Fig. 1 Water fluxes in the system (blue box) and inflamed tissue
(orange box). Blue box it is demonstrated that liver cells (pink box)
need water for degradation of glycogen, triglycerides, amino acids in
the urea cycle, and for gluconeogenesis in the context of the Cori cycle
(red arrows in the blue box). Similarly, degradation of muscle proteins
in muscle (brown box) and triglycerides in fat tissue (yellow box)
withdraw water from the system. An enormous amount of water is
needed for proliferation of immune cells in primary and secondary
lymphoid organs (green box) due to generation of DNA, membranes,
cytoskeletal proteins, and many others. Orange box the inflamed tissue
is separated from the system. In inflamed tissue activated cells, mainly
immune cells, use provided energy-rich substrates such as glucose,
amino acids such as glutamine and alanine, ketone bodies, and free
fatty acids to overcome the inflammatory state. In the process of
complete degradation of energy-rich substrates to CO2 and H2O, enor-
mous amounts of water are generated (black-edged box in orange box).
In an acute inflammatory situation, both, the system and the inflamed
tissue, loose water by several pathways (given as boxes below the blue
and orange box). C–C bond carbon–carbon bond, FFA free fatty acids,
GI tract gastrointestinal tract, HPA axis hypothalamic–pituitary–adre-
nal axis, Pi inorganic phosphate, SNS sympathetic nervous system. The
calculations of water fluxes is derived from biochemistry literature
[30–32]
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can shed new light on the pathophysiology of many age-
related and chronic inflammatory diseases. In the past,
several notable features of aging and chronic inflammatory
diseases were considered as independent phenomena in the
absence of a unifying model to explain both their
Fig. 2 Water fluxes between the system and inflamed tissue with water
loss in a transient acute inflammatory episode (a) and without water
loss in chronic inflammation (b). a Water fluxes with water loss in
acute inflammatory episodes. The inflamed tissue (orange box)
releases cytokines or stimulates sensory nerve endings (not shown) in
order to induce an energy appeal and water retention reaction in the
system (blue box). In the system, urinary water loss is inhibited and
water is needed for many important reactions for provision of energy-
rich substrates and immune cell proliferation (see Fig. 1). In the acute
situation, water is lost from the system and from inflamed tissue via
outer and inner surfaces. The water fluxes are in a balance. b Water
fluxes without water loss in chronic inflammation. Similarly, as before
in panel A the inflamed tissue activates water retention and energy
appeal reaction. However, due to low-grade inflammation without
fever and due to a lack of inflamed exposed surface areas, water is
not lost from the system and from inflamed tissue. Water can recircu-
late between activated immune cells and the system. In this scenario, it
does not matter how the inflamed tissue look like. It might be a
separated tissue such as an inflamed joint or an inflamed segment of
the aorta. However, it might also be the sum of disseminated activated
inflammatory cells in any tissue (orange box). It might also be the sum
of disseminated an activated cells in different parts of the body, which
might happen during aging when different organs present higher levels
of inflammatory activity. The logic behind the water flux between
system and inflamed cells remains the same. It is only important that
secreted cytokines of these inflammatory cells activate the energy
appeal and water retention reaction, and that water loss via inner and
outer surfaces is not increased. Chronic inflammation accompanied by
essential hypertension is a necessary consequence
532 J Mol Med (2012) 90:523–534prominence and coexistence. Consistent with emerging data
and an overarching model based on the role of evolution in
selecting patterns of host response, these features can now
be unified in terms of a redirection of energy-rich fuels from
energy stores to the activated immune system and activation
of the water retention system. This unified picture can help
explain sequelae of chronic inflammatory disease in terms
of a conceptual framework derived from studies of acute
inflammatory diseases.
The induction of systemic responses results from an
appeal for energy-rich substrates, called the energy appeal
reaction, and for water retention, called the water retention
reaction. The revised theory states that energy appeal and
water retention reaction have been positively selected for
transient inflammatory episodes but prolonged use of these
adaptive programs can in itself become pathogenic. Hope-
fully, recognition of the importance of energy and water
fluxes during both acute and chronic inflammation can
provide a new perspective of disease pathogenesis and lead
to better approaches for diagnosis and treatment.
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